Here's the live share price of Advanced Enzyme Technologies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Advanced Enzyme Technologies has declined 2.27% CAGR. Over the past year, the corresponding return has been -17.98%.
Advanced Enzyme Technologies’s current P/E of 23.11x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies | -0.33 | -7.65 | -10.51 | -9.84 | -17.98 | 0.28 | -2.27 |
| Sun Pharmaceutical Industries | -3.37 | -0.78 | 5.89 | 5.97 | -3.02 | 20.90 | 24.86 |
| Divi's Laboratories | -0.68 | -1.34 | 4.69 | -2.29 | 9.24 | 24.04 | 10.77 |
| Torrent Pharmaceuticals | -0.94 | -0.73 | 5.57 | 16.70 | 11.39 | 33.11 | 22.12 |
| Cipla | -0.96 | -1.13 | -5.12 | -0.05 | 1.73 | 10.95 | 13.53 |
| Dr. Reddy's Laboratories | 0.26 | 2.63 | -3.49 | -2.78 | 0.09 | 13.21 | 4.06 |
| Lupin | 1.86 | 3.51 | 3.57 | 8.46 | 0.97 | 42.74 | 16.86 |
| Zydus Lifesciences | -1.35 | -1.97 | -13.16 | -4.99 | -7.06 | 30.52 | 13.82 |
| Mankind Pharma | -1.46 | -4.00 | -19.07 | -9.31 | -23.90 | 14.45 | 8.44 |
| Aurobindo Pharma | 3.28 | -2.30 | 7.31 | 9.39 | -2.95 | 40.38 | 6.45 |
| Alkem Laboratories | -2.10 | -3.58 | 0.51 | 14.62 | 0.39 | 22.43 | 13.24 |
| Abbott India | -1.27 | -6.14 | -9.87 | -11.54 | -0.94 | 10.11 | 11.52 |
| Glenmark Pharmaceuticals | -0.05 | 6.17 | -7.33 | 17.78 | 28.29 | 67.47 | 30.53 |
| Laurus Labs | -0.22 | 0.98 | 10.07 | 53.14 | 79.08 | 37.85 | 23.47 |
| Biocon | 2.56 | -7.19 | 6.23 | 14.37 | 12.46 | 14.16 | -3.66 |
| GlaxoSmithKline Pharmaceuticals | -3.21 | 2.09 | -7.63 | -22.68 | 8.77 | 24.02 | 9.53 |
| Anthem Biosciences | -1.47 | 2.40 | -21.05 | -7.58 | -7.58 | -2.59 | -1.56 |
| Ipca Laboratories | -3.52 | -0.35 | 6.01 | 4.11 | -6.44 | 18.41 | 4.91 |
| Ajanta Pharma | -1.71 | 5.89 | 2.29 | 0.97 | -9.93 | 30.31 | 18.84 |
| J B Chemicals & Pharmaceuticals | -1.37 | -0.53 | 5.82 | 4.08 | -3.60 | 20.22 | 27.44 |
Over the last one year, Advanced Enzyme Technologies has declined 17.98% compared to peers like Sun Pharmaceutical Industries (-3.02%), Divi's Laboratories (9.24%), Torrent Pharmaceuticals (11.39%). From a 5 year perspective, Advanced Enzyme Technologies has underperformed peers relative to Sun Pharmaceutical Industries (24.86%) and Divi's Laboratories (10.77%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 308.01 | 307.79 |
| 10 | 308.71 | 308.76 |
| 20 | 313.06 | 311.15 |
| 50 | 314 | 315.14 |
| 100 | 321.48 | 317.9 |
| 200 | 310.63 | 324.68 |
In the latest quarter, Advanced Enzyme Technologies remained same as its previous close in promoter holding, while DII stake decreased to 6.41%, FII holding rose to 25.41%, and public shareholding moved up to 25.09% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 10,37,821 | 1.13 | 32.35 | |
| 8,72,022 | 1.8 | 27.18 | |
| 2,30,000 | 0.36 | 7.17 | |
| 1,90,000 | 0.42 | 5.92 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 17, 2025, 10:00 PM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 14, 2025, 12:15 AM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 12, 2025, 10:44 PM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Nov 12, 2025, 10:32 PM IST | Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 12, 2025, 4:04 PM IST | Advanced Enzyme Tech - Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30, 2025 |
Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 351.41 Cr. and Equity Capital is Rs. 22.38 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Advanced Enzyme Technologies is ₹304.25 as on Dec 18, 2025.
The Advanced Enzyme Technologies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Advanced Enzyme Technologies is ₹3,405.37 Cr as on Dec 18, 2025.
Today’s highest and lowest price of Advanced Enzyme Technologies are ₹307.05 and ₹297.35.
The 52-week high/low is the highest and lowest price at which Advanced Enzyme Technologies stock has traded in the past 52-week or nearly a year. The 52-week high of Advanced Enzyme Technologies is ₹391.85 and 52-week low of Advanced Enzyme Technologies is ₹257.85 as on Dec 18, 2025.
The Advanced Enzyme Technologies has shown returns of 0.16% over the past day, -7.65% for the past month, -10.51% over 3 months, -17.98% over 1 year, 0.28% across 3 years, and -2.27% over 5 years.
P/E ratio of and PB ratio of Advanced Enzyme Technologies are 23.11 and 2.54 on Dec 18, 2025. While the company gives a dividend yield of 1.71 per annum.